88 related articles for article (PubMed ID: 23256527)
1. Oral administration of hyaluronan reduces bone turnover in ovariectomized rats.
Ma J; Granton PV; Holdsworth DW; Turley EA
J Agric Food Chem; 2013 Jan; 61(2):339-45. PubMed ID: 23256527
[TBL] [Abstract][Full Text] [Related]
2. The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia.
Stancíková M; Svík K; Istok R; Rovenský J; Velebný V
Int J Tissue React; 2004; 26(1-2):9-16. PubMed ID: 15573687
[TBL] [Abstract][Full Text] [Related]
3. Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats.
Bakhsh A; Mustapha NM; Mohamed S
Nutrition; 2013 Apr; 29(4):667-72. PubMed ID: 23290096
[TBL] [Abstract][Full Text] [Related]
4. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
[TBL] [Abstract][Full Text] [Related]
5. Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats.
Horcajada MN; Habauzit V; Trzeciakiewicz A; Morand C; Gil-Izquierdo A; Mardon J; Lebecque P; Davicco MJ; Chee WS; Coxam V; Offord E
J Appl Physiol (1985); 2008 Mar; 104(3):648-54. PubMed ID: 18174393
[TBL] [Abstract][Full Text] [Related]
6. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
Li F; Yang X; Bi J; Yang Z; Zhang C
Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
[TBL] [Abstract][Full Text] [Related]
7. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus.
Zhao H; Li X; Li N; Liu T; Liu J; Li Z; Xiao H; Li J
Br J Nutr; 2014 Mar; 111(5):836-46. PubMed ID: 24073920
[TBL] [Abstract][Full Text] [Related]
8. Formononetin reverses established osteopenia in adult ovariectomized rats.
Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
[TBL] [Abstract][Full Text] [Related]
9. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
10. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
11. Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.
Sung MJ; Davaatseren M; Hur HJ; Kim HJ; Ryu SY; Choi YH; Cha MR; Kwon DY
Phytother Res; 2012 Aug; 26(8):1182-8. PubMed ID: 22821855
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
[TBL] [Abstract][Full Text] [Related]
13. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
14. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
15. The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin.
French DL; Muir JM; Webber CE
Phytomedicine; 2008 Dec; 15(12):1069-78. PubMed ID: 18693096
[TBL] [Abstract][Full Text] [Related]
16. Short-term administration of water-soluble silicon improves mineral density of the femur and tibia in ovariectomized rats.
Bae YJ; Kim JY; Choi MK; Chung YS; Kim MH
Biol Trace Elem Res; 2008 Aug; 124(2):157-63. PubMed ID: 18438624
[TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
[TBL] [Abstract][Full Text] [Related]
18. Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats.
Pytlik M; Cegieła U; Nowińska B; Folwarczna J; Sliwiński L; Kaczmarczyk-Sedlak I; Pytlik M; Bolek D; Korzeniowska H
Acta Pol Pharm; 2012; 69(1):113-20. PubMed ID: 22574514
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Pycnogenol® on ovariectomy-induced bone loss in rats.
Mei L; Mochizuki M; Hasegawa N
Phytother Res; 2012 Jan; 26(1):153-5. PubMed ID: 21710590
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
